The paper claims glucose+CO2 synergize to activate AtxA, the pXO1-encoded master virulence regulator, through a metabolic phosphorelay. Key quantitative findings: RNA-seq identified 291 differentially expressed genes under toxin-producing (CO2) conditions; FLIM showed AtxA-GFP lifetime dropping from 2.7 ns to 1.95 ns (28% faster decay) upon co-expression with PtsG-mCherry, confirming a physical interaction dependent on the EIIB domain; ΞptsG caused ~90% reduction in PA, LF, and EF; ΞptsG/Ξpyc completely abolished toxin production and was attenuated in C57BL/6J mice (n=15/group) with ~10-fold reduced dissemination at 48 h .
The mechanistic model β PEP β EI (EIIB) β PtsG β AtxA phosphorelay β is supported by phosphomimetic (H199D/H379D) and phosphoablative (H199A/H379A) mutants showing that AtxA-PtsG interaction is required regardless of phosphorylation state, and by metabolomics showing PEP decreased 0.49x while glucose accumulated 5.68x under toxin-inducing conditions .
Strengths include multi-modal evidence (RNA-seq, metabolomics, co-AP/MS, FLIM, genetics, in vivo virulence) and clear falsification criteria. Notable limitations: (1) single strain (Ames 35, pXO1+/pXO2β) β generalizability to fully virulent pXO1+/pXO2+ strains untested; (2) the exact phosphorylation mechanism of AtxA by PTS components remains undefined; histidine phosphorylation is labile in vivo; (3) only subcutaneous route tested; other infection routes may differ; (4) in vitro artificial media conditions; (5) AlphaFold-based structural claims about C402-H379 proximity are predictions, not resolved structures . Preprint status (not yet peer-reviewed) also warrants caution.
The model would fail if AtxA-PtsG interaction proved non-physical in independent assays, if EIIB C402 mutation did not abolish activity, if ΞptsG or Ξpyc restored toxin without complementation, or if virulence were unaffected in mice despite genetic perturbation .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.